There are physical differences between men and women that affect how cancer is detected and treated. In particular, lung cancer manifests differently in each gender. For example, women often face a delay in the diagnosis of adenocarcinoma, a common type of lung cancer.
This delay can be attributed to differences in how symptoms present and how the disease progresses. Women’s lung cancer might present with atypical symptoms, leading to misdiagnosis or delayed testing. Additionally, the biological and hormonal differences between genders can influence cancer development and response to treatment.
Recognizing these distinctions is crucial for improving early detection and tailoring treatment approaches to enhance outcomes for both men and women..